High dose chemotherapy in breast cancer--a thin red line between hype and hope
Toh, H.C.
Singapore Medical Journal 41(2): 86-88
2000
ISSN/ISBN: 0037-5675 PMID: 11063211 Document Number: 514474
Document emailed within 1 workday
Related Documents
Morrow, M. 1998: Primary chemotherapy for breast cancer: hope or hype? Seminars in Oncology 25(2 Suppl 3: 1-2Jönsson, P.E.; Malmberg, M.; Ericsson, M.; Ryden, S. 1991: Weekly dose adriamycin as first line chemotherapy in advanced breast cancer Anticancer Research 11(2): 877-879
Razis, E.D.; Samonis, G.; Cook, P.; Beer, M.; Mittelman, A.; Lake, D.E.; Feldman, E.J.; Puccio, C.; Ahmed, T. 1994: TMJ: a well-tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancer Journal of Medicine 25(3-4): 241-250
Bearman, S.I.; Shpall, E.J.; Jones, R.B.; Cagnoni, P.J.; Ross, M. 1996: High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer Seminars in Oncology 23(1 Suppl 2: 60-67
Leonard, R.C. 1998: High-dose chemotherapy in metastatic breast cancer Lancet 351(9107): 986
Filip, S.; Petera, J.; Odrázka, K.; Bláha, M. 2000: The current look at high-dose chemotherapy in breast cancer minireview Neoplasma 47(5): 261-268
Meropol, N.J.; Overmoyer, B.A.; Stadtmauer, E.A. 1992: High-dose chemotherapy with autologous stem cell support for breast cancer Oncology 6(12): 53-60; 63; Discussion: 63-4 69
Kennedy, M.J. 1997: Issues relating to the inclusion of high-dose chemotherapy in breast cancer treatment guidelines Oncology 11(11a): 121-126
Antimi, M. 1998: High-dose chemotherapy of breast cancer with hematopoietic protection; current status and prospectives La Clinica Terapeutica 149(921): 7-9
Kubota, O.; Onuki, Y.; Uchiyama, T.; Oishi, K.; Takeda, M. 2012: Efficacy of high-dose toremifene as a second-line hormone therapy in patients with advanced or metastatic breast cancer resistant to aromatase inhibitor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(5): 753-757
Stemmler, H.J.; Salat, C.; Lindhofer, H.; Menzel, H.; Untch, M.; Kahlert, S.; Konecny, G.; Sauer, H.; Ledderose, G.; Heinemann, V.; Kolb, H.J. 2005: Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study Anticancer Research 25(4): 3047-3054
Rühl, U. 2000: Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(4): 196-197
Chen, T.L.; Passos-Coelho, J.L.; Noe, D.A.; Kennedy, M.J.; Black, K.C.; Colvin, O.M.; Grochow, L.B. 1995: Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Cancer Research 55(4): 810-816
Van Rie, A.; Page-Shipp, L.; Scott, L.; Sanne, I.; Stevens, W. 2010: Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Review of Molecular Diagnostics 10(7): 937-946
Lucey, C.; Westphal, J.R. 1998: New approach to administrative medical decision-making: evidence-based medicine using high dose chemotherapy/bone marrow transplant for breast cancer Southern Medical Journal 91(2): 196-201
Tokuda, Y. 2000: High-dose chemotherapy for treatment of breast cancers Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 292-297
Pacetti, U.; Veltri, E.; Fattoruso, S.Ileana.Sara.; Cardillo, F.D'Assisi.; Evangelista, S.; Cognetti, F.; Fabi, A. 2013: Single-dose palonosetron and dose-reduced regimen of dexamethasone in preventing nausea and vomiting by anthracycline-including chemotherapy in patients with early breast cancer Anticancer Research 33(4): 1721-1724
Yoshimatsu, K.; Yokomizo, H.; Fujimoto, T.; Umehara, A.; Otani, T.; Matsumoto, A.; Osawa, G.; Ogawa, K. 2007: Pilot study of simplified low-dose S-1 plus CPT-11 as first-line chemotherapy for patients with advanced colorectal cancer Anticancer Research 27(3b): 1657-1661
Vici, P.; Foggi, P.; Colucci, G.; Capomolla, E.; Brandi, M.; Giotta, F.; Gebbia, N.; Di Lauro, L.; Valerio, M.Rosaria.; Paoletti, G.; Belli, F.; Pizza, C.; Giannarelli, D.; Lopez, M. 2005: Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer Anticancer Research 25(2b): 1309-1314
Fiorentini, G.; Tsetis, D.; Bernardeschi, P.; Varveris, C.; Rossi, S.; Kalogeraki, A.; Athanasakis, E.; Dentico, P.; Kanellos, P.; Biancalani, M.; Almarashdah, S.; Zacharioudakis, G.; Saridaki, Z.; Chalkiadakis, G.; Xynos, E.; Zoras, O. 2003: First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer Anticancer Research 23(5b): 4339-4345